Dr. Lawenda's Cardiac Risk Panel #2
Dr. Lawenda's Cardiac Risk Panel #2 includes the Lipid Panel, Apolipoprotein B, Homocysteine, and Lipoprotein (A).
Lipids are a group of fats and fat-like substances that are important constituents of cells and sources of energy. They contribute to a variety of functions in the body such as the production of hormones which are essential for growth and reproduction, the development of cells in tissues and organs throughout the body, and the absorption of nutrients from the food you eat. Excess lipids can cause the buildup of plaques in the blood vessels. Plaques cause the narrowing or blockage of blood vessels which can lead to heart disease or events such as heart attack or stroke. Monitoring and maintaining healthy lipid levels is important in staying healthy.
LDL is referenced as the "bad" cholesterol due to the damage it can cause the heart if the levels are too high. Apolipoprotein is the main protein in LDL cholesterol and its job is to measure the amount of the "bad" cholesterol in the blood. High levels could point to high cholesterol which could potentially lead to heart disease.
The homocysteine blood test helps diagnose B6 and B12 Deficiency, as well as, a Folate Deficiency. It is also used to identify patients who may be at risk for heart disease and/or strokes.
Homocysteine is an amino acid that can be linked to several vitamins like folic acid, B6, and B12. Deficiencies of these vitamins may cause elevated levels of homocysteine. Research suggests that people with elevated homocysteine levels have a much greater risk of heart attack or stroke than those with normal levels. Additionally, increased concentrations of homocysteine have been linked to an increase in blood clots, which can lead to strokes, heart attack, and blood vessel blockages in any part of the body.
Lipoprotein (a) has been called a powerful predictor of premature coronary artery disease. Excess Lp(a) concentrations are associated with an increased risk of cardiac death in patients with acute coronary syndromes and with restenosis after angioplasty (PTCA) and coronary bypass procedures. In general, concentrations >30 mg/dL of Lp(a) in serum are associated with a two- to sixfold increase in risk, depending on the presence of other risk factors.
Trusted, Secure, & Confidential
Shop All Tests